BP000552-ENZ-536: Recombinant Human Uroporphyrinogen Decarboxylase (UROD) Enzyme
Source: E. coli-derived.
A single, non-glycosylated polypeptide chain containing 387 amino acids (1-367 a.a.) and having a molecular mass of 43 kDa.
Purity: > 95% by SDS-PAGE.BP002567-PKA-029: Recombinant Human Mitogen-Activated Protein Kinase Kinase 2 (MAP2K2)
Source: E. coli-derived.
Purity: > 90.0% as determined by SDS-PAGE.BP001526-PRO-812: Recombinant Human CutA Divalent Cation Tolerance Homolog (CUTA) Protein
Source: E. coli-derived.
Purity: > 95% as determined by SDS-PAGE.APIM050191: LY-3200882 (LY3200882)
CAS No.: 1898283-02-7.
Purity: >99.5% by HPLC at 214 and 254 nm.
QC: HPLC-MS, H-NMR, and Quantitative Elemental Analysis Report.
Solubility: Refer to Certificate of Analysis.APIM050267: PCI-27483
CAS No.: 871266-63-6.
Purity: 99.5% (HPLC at 254 nm).
QC: HPLC, 1HNMR and Quantitative Elemental Analysis.
Solubility: Soluble in DMSO.APIM050318: DOXORUBICIN
CAS No.: 23214-92-8.
Purity: 99% (HPLC).
QC: HPLC, 1HNMR, Quantitative Elemental Analysis.
Solubility: Soluble in water.APIM050355: BEXAROTENE
CAS No.: 153559-49-0.
Purity: >99% (HPLC).
QC: 1HNMR, HPLC and MS.
Solubility: Soluble in DMSO, Alcohols, Common Organic Solvents.C042P: Clenoliximab Biosimilar, CD4 Monoclonal Antibody
Recombinant Humanized IgG4 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade clenoliximab biosimilar specifically binds to the human CD4.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by clenoliximab.